ADRs Gain Overall Monday; AstraZeneca's ADRs Weaken After Vaccine News
|11/23/2020 | 05:02pm|
By Micah Maidenberg
The S&P/BNY Mellon index of American depositary receipts gained 0.9% Monday to 148.89. The European index closed at 121.61, 0.7% higher. The emerging-markets and the Asian indices rose 1.2% and 1.1%, respectively, closing at 392.17 and 221.5. The index for Latin American ADRs increased 1.6% to 392.17.
AstraZeneca PLC's American depositary receipts ended down 1.1%. AstraZeneca and the University of Oxford said Monday their Covid-19 vaccine was effective as much as 90% of the time in preventing infections without major side effects. Moderna Inc. has also developed a vaccine, as have Pfizer Inc. and Germany's BioNTech SE, while China and Russia have deployed their own vaccines to combat Covid-19.
ADRs for gold producers fell in tandem with lower prices for the precious metal on Monday. Gold Fields Ltd. receipts were off almost 5% to $9.17 while Harmony Gold Mining Co.'s dropped 7.3% to $4.32. AngloGold Ashanti Ltd.'s ADR fell 4.7% to $21.51.
Write to Micah Maidenberg at firstname.lastname@example.org
(END) Dow Jones Newswires
Dow, S&P 500 dragged lower by Intel, IBM
Dow, S&P 500 Decline But Post Gains for the Week
Dow Drops But Notches Weekly Gain
Stocks on Track for Weekly Gains
Stocks Drop, on Track to End Strong Week on Muted Note